Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes

Obese and diabetic individuals are at increased risk for impairments in diastolic relaxation and heart failure with preserved ejection fraction. The impairments in diastolic relaxation are especially pronounced in obese and diabetic women and predict future cardiovascular disease (CVD) events in thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Habibi, Javad, Aroor, Annayya R., Sowers, James R., Jia, Guanghong, Hayden, Melvin R., Garro, Mona, Barron, Brady, Mayoux, Eric, Rector, R. Scott, Whaley-Connell, Adam, DeMarco, Vincent G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237274/
https://www.ncbi.nlm.nih.gov/pubmed/28086951
http://dx.doi.org/10.1186/s12933-016-0489-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237274/
https://www.ncbi.nlm.nih.gov/pubmed/28086951
http://dx.doi.org/10.1186/s12933-016-0489-z

Ejemplares similares